{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:39:48Z","timestamp":1790278788971,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2019.00523","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T06:44:40Z","timestamp":1565073880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"10","author":[{"given":"Vijaya Padma","family":"Kotapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Bachu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahwish","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarij","family":"Zubair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1176\/ajp.152.1.76","article-title":"A family study of obsessive-compulsive disorder","volume":"152","author":"Pauls","year":"1995","journal-title":"Am J Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.2.121","article-title":"A 40-year follow-up of patients with obsessive- compulsive disorder","volume":"56","author":"Skoog","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2004.00302.x","article-title":"Long-term outcome of pediatric obsessive\u2013compulsive disorder: a meta-analysis and qualitative review of the literature","volume":"110","author":"Stewart","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","author":"Pediatric","year":"2004","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2012.01.005","article-title":"Developmentally informed pharmacotherapy for child and adolescent depressive disorders","volume":"21","author":"Sakolsky","year":"2012","journal-title":"Child Adolesc Psychiatr Clin"},{"key":"B6","article-title":"Tricyclic Antidepressants and Monoamine Oxidase Inhibitors for the Treatment of Child and Adolescent Psychiatric Disorders","volume-title":"Pharmacotherapy of Child and Adolescent Psychiatric Disorders","author":"Heleniak","year":"2011"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.11.1919","article-title":"Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive- compulsive disorder","volume":"160","author":"Geller","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00004714-198206000-00009","article-title":"Intolerable side effects of clomipramine","volume":"2","author":"Ananth","year":"1982","journal-title":"J Clin Psychopharmacology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199709000-00006","article-title":"Adverse effects of clomipramine","volume":"36","author":"Brasic","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59259-792-5","volume-title":"Pharmacotherapy of depression","author":"Ciraulo","year":"2004"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.janxdis.2013.10.007","article-title":"Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive\u2013compulsive disorder: a meta-analysis","volume":"28","author":"S\u00e1nchez-Meca","year":"2014","journal-title":"J Anxiety Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810220042005","article-title":"Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder: behavioral and biological results","volume":"47","author":"Pigott","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"B13","article-title":"Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison","volume":"55","author":"Freeman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199604000-00004","article-title":"Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison","volume":"16","author":"Koran","year":"1996","journal-title":"J Clin Psychopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00004850-200015020-00002","article-title":"Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder","volume":"15","author":"Mundo","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","author":"Geller","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B17","article-title":"Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder","volume-title":"NICE","author":"Britain","year":"2005"},{"key":"B18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00787-014-0613-0","article-title":"Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive\u2013compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial","volume":"24","author":"Skarphedinsson","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0005-7894(05)80054-1","article-title":"The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"36","author":"Abramowitz","year":"2005","journal-title":"Behav Ther"},{"key":"B20","article-title":"Behavioral and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents","volume-title":"Cochrane Libr","author":"O\u2019Kearney","year":"2006"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.2007.01875.x","article-title":"Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder","volume":"49","author":"Watson","year":"2008","journal-title":"J. Child Psychol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ebch.541","article-title":"Cochrane Review: pharmacotherapy for anxiety disorders in children and adolescents. Evidence-Based Child Health","volume":"5","author":"Ipser","year":"2010","journal-title":"Cochrane Rev J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/da.22232","article-title":"Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive\u2013compulsive disorder: a systematic review and meta-analysis of head- to-head randomized controlled trials","volume":"31","author":"Romanelli","year":"2014","journal-title":"Depress Anxiety"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2013.09.007","article-title":"Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive\u2013compulsive disorder","volume":"51","author":"Storch","year":"2013","journal-title":"Behav Res Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199211000-00011","article-title":"Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder","volume":"31","author":"Riddle","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/cap.2000.10.295","article-title":"The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive- compulsive disorder","volume":"10","author":"Neziroglu","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000177324.40005.6f","article-title":"Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder","volume":"44","author":"Asbahr","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0634-z","article-title":"A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive- compulsive disorder (OCD)","volume":"18","author":"Alaghband-Rad","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200212000-00014","article-title":"Fluoxetine in Children and Adolescents With OCD: a Placebo-Controlled Trial","volume":"41","author":"Liebowitz","year":"2002","journal-title":"J. Child Adolesc Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200107000-00011","article-title":"Fluoxetine Pediatric OCD Study Team. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial","volume":"40","author":"Geller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000138356.29099.f1","article-title":"Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"43","author":"Geller","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B32","volume-title":"OCD in children and adolescents: A cognitive-behavioral treatment manual","author":"March","year":"1998"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200102000-00017","article-title":"Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial","volume":"40","author":"Riddle","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B35","volume-title":"Trim and fill: a simple funnel plot based method of testing and adjusting for publication bias in meta-analyses","author":"Taylor","year":"1998"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3102\/10769986008002157","article-title":"A fail-safe N for effect size in meta-analysis","volume":"8","author":"Orwin","year":"1983","journal-title":"J Educational Stat"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Stat Med"},{"key":"B38","unstructured":"Selective serotonin re- uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)\n            SoomroGM\n            AltmanD\n            RajagopalS\n            Oakley BrowneM\n          10.1002\/14651858.CD001765.pub3Cochrane Library12008"},{"key":"B39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.psychres.2015.01.015","article-title":"The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: views based on a systematic review and meta-analysis","volume":"227","author":"Ivarsson","year":"2015","journal-title":"Psychiatry Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10862-005-2411-y","article-title":"Measuring change in OCD: sensitivity of the Obsessive-Compulsive Inventory-Revised","volume":"27","author":"Abramowitz","year":"2005","journal-title":"J Psychopathol Behav Assess"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.170","article-title":"Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)\u2014a randomized clinical trial","volume":"71","author":"Freeman","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/08039488.2014.941395","article-title":"Standard individual cognitive behaviour therapy for paediatric obsessive\u2013compulsive disorder: a systematic review of effect estimates across comparisons","volume":"69","author":"Skarphedinsson","year":"2015","journal-title":"Nord J Psychiatry"},{"key":"B43","volume-title":"Clinical epidemiology: how to do clinical practice research","author":"Haynes","year":"2012"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T06:44:50Z","timestamp":1565073890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2019.00523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":43,"alternative-id":["10.3389\/fpsyt.2019.00523"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2019.00523","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"article-number":"523"}}